To study the decreasing responsiveness of the immune system during aging, influenza virus specific cellular immunity was investigated in a cohort of healthy blood donors between 18 and 70 years of age. The percentage of influenza A virus specific T cells was determined by flow cytometry and found not to change during aging. After stimulation with phorbol 12-myristate 13-acetate and ionomycin, an increase in the percentage of IFN-␥ and IL-4 producing CD8 ϩ T cells was observed during aging. In addition, the cytotoxic T lymphocyte (CTL) activity was investigated in two additional groups of five donors, 18-20 and 68-70 years of age. The lytic capacity of purified CD8 ϩ T cells, after in vitro stimulation of peripheral blood mononuclear cells with influenza A virus, seemed lower in 68-to 70-year-old donors than in 18-to 20-year-old donors. Therefore we conclude that the reduced CTL activity in the elderly is not the result of a lower frequency of virus-specific T cells, but more likely the result of impaired antigen-specific proliferation or lower lytic capacity of these cells. © 2002 Elsevier Science (USA) 
INTRODUCTION
The elderly form a growing group at high risk for complications related to infections with respiratory syncytial virus (RSV) and influenza virus, resulting in high morbidity and mortality rates (Barker and Mullooly, 1980; Falsey et al., 1995; Falsey and Walsh, 2000; Gross et al., 1988; Mlinaric-Galinovic et al., 1996) . The more severe clinical course of these virus infections in the elderly can partially be attributed to a reduced responsiveness of the immune system, also known as immunosenescence. Immunosenescence has been associated with reduced T cell proliferative responses to antigens and mitogens, reduced interleukin-2 production, increased interferon-␥ (IFN-␥) production, and reduced expression of the costimulatory molecule CD28 on T cells (Globerson and Effros, 2000; Miller, 1996; Pawelec et al., 1997; Wick and Grubeck-Loebenstein, 1997a) . In the elderly this phenomenon may also underlie lower vaccine efficacy (de Jong et al., 2000) .
In addition to the induction of virus-specific antibodies, the induction of cellular immune responses has been shown to contribute to protective immunity against influenza. In mouse models the protective effect of CD8 ϩ cytotoxic T lymphocytes (CTL) has been demonstrated against homologous and heterologous subtypes of influenza virus (Fu et al., 1999; Kuwano et al., 1990; Ulmer et al., 1998; Yap et al., 1978) . Also in humans protective immunity was associated with the induction of CTL responses (Bender et al., 1992; McMichael et al., 1983) . Furthermore, the selective pressure of CTL-mediated immunity indicates a role for CTL in the control of influenza virus replication in infected individuals (Boon et al., 2002b; Voeten et al., 2000) . It has been described that CTL activity is reduced in the elderly both in vivo (Globerson and Effros, 2000) and in vitro (Mbawuike et al., 1993 (Mbawuike et al., , 1997 Powers, 1993) . Several steps determine the extent of CTL activity after stimulation with antigen during infection. These steps include the virus-specific CTL precursor frequency (CTLp) in the pool of memory cells, the stimulation and subsequent expansion of virus-specific cells, and the cytolytic effector function per cell. The latter is still a matter of debate since some reports describe a reduced expression of perforin and granzyme in the elderly, while others describe no change in CTL activity on a per cell basis (Globerson and Effros, 2000) . Currently no data are available on the frequency of virusspecific CTL during aging. In the present study, the CTLp frequency of influenza virus specific CTL was investigated in a cohort of 87 donors of various ages, ranging from 18 to 70 years. It was found that the number of virus-specific CTL remained stable during aging. Thus the reduced in vitro CTL activity of activated peripheral blood mononuclear cells (PBMC) obtained from elderly people cannot be explained by fluctuations in the quan-tity of virus-specific CTL. Functional studies performed with PBMC from a group of 18-to 20-year-old individuals and a group of 68-to 70-year-old individuals indicated that the observed reduction of CTL activity in vitro is more likely the result of a reduced proliferation of T cells upon activation or a reduced lytic capacity of the CTL.
RESULTS

Serology
The sera of all 87 donors were tested for the presence of influenza A virus specific antibodies. Only one donor had no hemagglutination inhibition (HI) titer against any of the influenza viruses. The remaining 86 donors had serum antibodies against influenza A virus (H1N1 or H3N2), indicating that they had been infected with influenza A virus.
Precursor frequency of influenza A virus specific T cells
Of the 82 donors tested for the presence of influenza A virus specific CD3 ϩ CD8 ϩ cells, 45 donors (55%) were positive and had a higher percentage IFN-␥ϩ cells within the CD3 ϩ CD8 ϩ fraction of the PBMC than the cutoff value of 0.11% (dotted line, Fig. 1C ). Comparing the percentage of influenza A virus specific IFN-␥ϩ cells in the CD3 ϩ CD8 ϩ population among donors of various ages, no age-related differences were observed (average ϭ 0.23%, solid line, Fig. 1C , P ϭ 0.778). In addition to CTLp frequency, the percentage of virus-specific cells in the CD3 ϩ CD4 ϩ population was determined and found to be lower than the frequency of virus-specific CD3 ϩ CD8 ϩ cells. In 33 (40%) of 85 donors tested for virus-specific INF-␥ϩ CD3 ϩ CD4 ϩ cells the percentage IFN-␥ϩ cells in the CD3 ϩ CD4 ϩ cells was higher than the cutoff value (dotted line, Fig. 1D ). The average percentage IFN-␥ϩ cells in CD3 ϩ CD4 ϩ was 0.16% in these 33 donors, while the overall average percentage of virus-specific cells in the CD3 ϩ CD4 ϩ population was 0.07%. Again, no agerelated differences were found in the percentage of IFN-␥ϩ CD3 ϩ CD4 ϩ cells (solid line, Fig. 1D , P ϭ 0.657). Finally, the frequency of all influenza A virus specific CD3 ϩ cells was determined in 79 donors, of whom 56 donors (71%) proved to be positive. The average percentage IFN-␥ϩ cells in the CD3 ϩ population in all donors was 0.21%, ranging from 0.0 to 1.49%. The frequency of virus-specific cells in the CD3 ϩ population also did not differ significantly (P ϭ 0.628) between donors of different ages (data not shown).
Percentage of IFN-␥ and interleukin-4 producing T cells after PMA (phorbol 12-myristate-13-acetate) and ionomycin stimulation
The percentage IFN-␥ϩ cells within the CD3 ϩ CD8 ϩ population was found to increase during aging after stimulation of PBMC with PMA/ionomycin (P Յ 0.001, closed symbol, Fig. 2A ). A similar increase, although less pronounced, was found in CD3 ϩ cells (P ϭ 0.001, open symbol, Fig. 2A) . The difference between percentage IFN-␥ϩ cells in the CD3 ϩ CD8 ϩ population and in the CD3 ϩ population increased gradually during aging. Also the percentage interleukin-4 (IL-4) producing cells within the CD3 ϩ CD8 ϩ compartment increased during aging (P ϭ 0.003, Fig. 2B ). Since the percentage of both IFN-␥ϩ and IL-4ϩ cells was determined in the CD8 ϩ T cell fraction, the ratio between IFN-␥ϩ and IL-4 ϩ CD8 ϩ T cells was calculated in cytokine-positive donors. The ratio of IFN-␥ vs IL-4 producing CD3 ϩ CD8 ϩ cells after PMA/ionomycin stimulation increased during aging, although this change was not statistically significant (P ϭ 0.124, Fig. 2C ).
FIG. 1. Precursor frequency of influenza A virus specific T cells in fresh PBMC of donors of various ages. PBMC were stimulated ex vivo with influenza A virus (H3N2, Resvir-9) as described under Materials and Methods. A and B show intracellular IFN-␥ staining in unstimulated (A) and influenza A virus (Resvir-9) stimulated (B) CD3 ϩ cells. The percentage IFN-␥ϩ cells in a large number of donors of various ages is depicted within the CD3 ϩ CD8 ϩ cells (C, n ϭ 82) and CD3 ϩ CD4 ϩ cells (D, n ϭ 85). The cutoff value is represented by the dotted line (---) and the correlation between percentage IFN-␥ϩ cells and age by the solid line (-).
Influenza virus specific CTL effector function in 18-to 20-and 68-to 70-year-old donors
Once it was concluded that the frequency of influenza A virus specific CTL did not fluctuate during aging and therefore as such did not contribute to a reduced CTL activity of PBMC from the elderly, it was decided to investigate the CTL activity of PBMC in greater detail. Therefore PBMC of five donors between 18 and 20 years and five donors between 68 and 70 years of age were stimulated in vitro with influenza A virus.
Lymphoproliferative response of PBMC
First the PBMC obtained from the five 18-to 20-and 68-to 70-year-old donors were evaluated for signs of immunosenescence. The T cell proliferative response after stimulation with influenza antigen at different concentrations was significantly higher in 18-to 20-year-old donors than in donors 68-70 years of age (avg. P ϭ 0.025, Fig. 3A ). This difference was not dependent on the dose of antigen used for stimulation of the PBMC.
Phenotype of CD4 ϩ and CD8 ϩ T cells
The CD45RA, CD45RO, and CD28 expression was determined in both CD4 ϩ and CD8 ϩ T cells. In the CD3 ϩ CD4 ϩ cells of 18-to 20-year-old donors the CD45RA and CD45RO expression was evenly distributed (Fig. 3B ), while the majority of the CD3 ϩ CD8 ϩ cells expressed CD45RA (Fig. 3D ). In the 68-to 70-year-old donors both the CD4 ϩ and the CD8 ϩ T cells mainly expressed CD45RO (Figs. 3B and 3D) . The number of CD4 ϩ and CD8 ϩ T cells expressing CD28 was reduced in donors 68-70 years of age, but this reduction was more pronounced in CD8 ϩ T cells (Figs. 3C and 3E).
CTL activity of influenza virus stimulated PBMC
Following in vitro stimulation of PBMC with influenza A virus, the CTL effector cells were tested for their ability to lyse influenza A virus infected autologous target cells. In Fig. 4 , the specific lysis was plotted against the CD8: Target cell ratio for the 18-to 20-year-old ( Fig. 4A ) and the 68-to 70-year-old ( Fig. 4B ) donors, enabling us to determine the percentage of specific lysis at a given CD8: Target cell ratio, which is a measure for both the lytic activity of the effector cells and the number of virusspecific cells present in the effector cell population. The average percentage specific lysis at a CD8:Target cell ratio of 10:1 was similar between both groups. The slopes of the curves are an indication for the lytic capacity of the virus-specific effector cells. The lytic capacity of the effector cells, calculated as the average correlation coefficient, seemed lower in the group of 68-to 70-year-old donors, although the difference was not statistically significant (P ϭ 0.25, Fig. 4C ).
DISCUSSION
In the present article it was shown that precursor frequencies of influenza A virus specific T cells remain stable during aging, indicating that the reduced CTL activity of T cells after stimulation in vitro in the elderly is not the result of a reduction in the numbers of virusspecific cells during aging, but more likely the result of impaired antigen-specific proliferation or lower lytic capacity of these cells.
The frequency of influenza virus specific T cells was determined ex vivo in fresh PBMC of donors of various ages. First, PBMC were infected with influenza A virus for 6 h, allowing the antigen-presenting cells (APC) to present viral antigens in both HLA class I and HLA class II molecules on the surface of the cell (Kuijpers et al., FIG. 2 . Percentage IFN-␥ and IL-4 positive T cells in PBMC after stimulation with PMA/ionomycin. PBMC were stimulated ex vivo with PMA/ionomycin for 6 h at 37°C, followed by intracellular IFN-␥ and IL-4 staining, as described under Materials and Methods. (A) Percentage IFN-␥ϩ cells within the CD3 ϩ CD8 ϩ cell population (F) and CD3 ϩ cell population (E) in donors of various ages. A significant increase in the percentage IFN-␥ϩ cells in the CD3 ϩ CD8 ϩ cells (-, P Ͻ 0.001) and in the CD3 ϩ cells (---, P ϭ 0.001) was observed during aging. (B) Percentage of CD3 ϩ CD8 ϩ cells producing IL-4 in donors of various ages. A significant increase (-, P ϭ 0.003) in the percentage IL-4ϩ CD3 ϩ CD8 ϩ cells during aging was observed. (C) Ratio between IFN-␥ and IL-4 producing CD3 ϩ CD8 ϩ cells did not change during aging (-, P ϭ 0.124). 1992). In the PBMC population the APC are B cells and monocytes, of which the latter can be efficiently infected by influenza virus (Nichols et al., 2001) . Previous studies have shown that the APC within the influenza virus infected PBMC can stimulate high numbers (2-4%) of virus-specific CD8 ϩ T cells (Boon et al., 2002a) . The induction of apoptosis through the Fas-FasL pathway, as recently described (Nichols et al., 2001) , does not interfere with our assay, since in vitro experiments with FasLspecific monoclonal antibodies (MAb) confirmed that apoptosis of T cells is a random process (unpublished observation).
The average frequency of influenza A virus specific IFN-␥ producing cells within the CD8 ϩ T cell population remained stable during aging and was similar to previously reported precursor frequencies of EBV-, influenza A virus-, or measles virus specific CD8 ϩ T cells (Boon et al., 2002a; Crucian et al., 2001; Nanan et al., 2000) . The average percentage virus-specific CD8 ϩ T cells (0.23%) is higher than the average percentage virus-specific CD4 ϩ T cells. A difference in the regulation of T cell memory between CD4 ϩ T cells and CD8 ϩ T cells could be the basis of a lower influenza virus specific CD4 ϩ T cell frequency (Homann et al., 2001) . In our cohort a decline in the percentage CD3 ϩ cells in PBMC during aging was observed (P ϭ 0.022) which could conceal a possible decline in the frequency of influenza A virus specific CTL in PBMC. However, when the frequency of virus-specific CTL was analysed as a frequency of virusspecific CD8 ϩ cells of all PBMC, still no significant difference (P ϭ 0.841) in frequency of influenza A virus specific cells was observed during aging. The finding that numbers of influenza A virus specific T cells do not change during aging, even after adjusting for number of CD3 ϩ T cells in the PBMC population, conflicts with other studies which describe a reduced IFN-␥ production after stimulation with influenza virus (Bernstein et al., 1998; Castle, 2000; Mbawuike et al., 1997; Ouyang et al., 2000) . In these studies ELISA systems were used to measure cytokine production in culture supernatant of PBMC which had been stimulated in vitro for several days.
Results obtained after prolonged in vitro stimulation do not account for differences in proliferation of lymphocytes between young and old donors (this article; Bernstein et al., 1998; Globerson and Effros, 2000) . Using flow cytometry, cytokines can be detected in activated T cells after a short period of stimulation which makes it possible to quantify numbers of virus-specific cells without the need of in vitro proliferation of these cells. It could be anticipated that in light of recurrent infections with influenza A virus throughout a lifetime the CTLp frequency would increase during aging. Our studies indicate, however, that this is not the case and that CTLp frequencies remain stable. This would imply that after recurrent infections the number of memory CD8 ϩ T cells return to a certain basic level.
When the IFN-␥ production of PBMC upon a mitogenic stimulation between young and older individuals was compared, conflicting results have been obtained (Born et al., 1995; Cakman et al., 1996; Fagiolo et al., 1993; Karanfilov et al., 1999; Sakata-Kaneko et al., 2000; Yen et al., 2000) . Our results, using flow cytometry, show a significant increase in the percentage IFN-␥ϩ CD8 ϩ T cells and IFN-␥ϩ CD3 ϩ cells, which is in accordance with previous studies (Bandres et al., 2000; Sakata-Kaneko et al., 2000) . The increase in the number of IFN-␥-producing T cells coincides with an increased CTL memory pool in the elderly (this paper; Effros, 2001; Wick and Grubeck-Loebenstein, 1997b) . It has been reported that after stimulation of memory T cells a large variety of cytokines, including IL-4 and IFN-␥, are produced (Beckman et al., 1994) . This could account for the increase in percentage IL-4ϩ and IFN-␥ϩ CD8 ϩ T cells after PMA/ ionomycin stimulation. When the frequencies of IFN-␥ producing cells after stimulation with PMA and influenza A virus were compared, a significant correlation was found (P ϭ 0.028). To rule out a possible effect of high PMA responders on the frequency of IFN-␥ producing influenza A virus specific CD8 ϩ T cells, statistical analysis was performed excluding these high PMA responders (Ͼ60% IFN-␥ϩ cells within CD8 ϩ T cells). Again no statistical difference in the frequency of influenza virus specific IFN-␥ϩ CD8 ϩ T cells was found during aging (P ϭ 0.617), indicating that the high PMA responders in the elderly did not mask a possible decline in the frequency of influenza virus specific CTL during aging.
In addition to an increase in the number of IFN-␥ producing CD8 ϩ T cells the percentage IL-4ϩ CD8 ϩ T cells, after PMA/ionomycin stimulation, was also increased during aging. This in contrast to a previous study (Bandres et al., 2000) reporting no difference in the number of IL-4ϩ producing CD8 ϩ T cells during aging. However with ELISA systems an increase in IL-4 production in CD8 ϩ T cells of older donors was found (Yen et al., 2000) . The ratio IFN-␥ to IL-4 producing CD8 ϩ T cells was increased in older donors, suggesting a shift toward Th1 phenotype of CD8 ϩ T cells. In some studies a shift FIG. 4 . Reduced lytic activity of CD8 ϩ T cells after in vitro stimulation PBMC with influenza A virus. PBMC from five donors between 18 and 20 years old and five donors between 68 and 70 years old were stimulated with influenza A virus (Resvir-9). After eight days of culture, the CD4 ϩ and CD16 ϩ cells were depleted and the remaining effector cells tested for lytic capacity in a CTL assay against influenza A virus infected or uninfected autologous target cells (BLCL) at the indicated CD8:Target cell ratio. The figure shows the percentage lysis of infected target cells minus uninfected target cells for five 18-to 20-year-old donors (A) and five 68-to 70-year-old donors (B). The slopes of the trendlines (specific lysis vs CD8:Target cell ratio) for the five donors between 18 and 20 years of age (F) and five donors between 68 and 70 years of age (E) was plotted (C). toward a Th2 response during aging is described, although these studies measured cytokine production in supernatant of in vitro cultured PBMC as opposed to activated CD8 ϩ T cells obtained ex vivo. A shift toward Th1 phenotype was also reported after PMA/ionomycin stimulation of purified CD4 ϩ T cells (Sakata-Kaneko et al., 2000) .
To further investigate the CTL immunity to influenza A virus in the elderly, CTL activity of purified CD8 ϩ T cells obtained from five 68-to 70-year-old individuals was investigated and compared with that of five 18-to 20year-old individuals. Functional and phenotypic differences between the groups indicated immunosenescence, a shift from naïve to memory cell phenotype, reduced CD28 expression, and lower proliferative capacity (Effros, 2001) . The lysis of virus-infected cells by virusspecific CTL is dependent on several variables, including the number of virus-specific cells in the effector cell population and the lytic capacity of these cells. A measure of the latter can be deduced from the slope of the logarithmic trendline of the plots shown in Fig. 4 . Our results suggest that the lytic capacity per cell is lower in older donors than in young donors, which could be explained by a reduced perforin or granzyme expression (Rukavina et al., 1998) . More studies in larger cohorts of donors are required to further investigate the lytic capacity of CTL during aging. At certain CD8:Target ratios (10:1) essentially no difference in CTL activity was observed between PBMC obtained from 68-to 70-year-old donors and the PBMC obtained from 18-to 20-year-old individuals. The addition of exogenous IL-2 in our experiments may have compensated for the reduction in CTL activity of in vitro expanded CTL observed without the addition of IL-2 (Mbawuike et al., 1993 (Mbawuike et al., , 1997 Powers, 1993) . The reduced CTL activity in the elderly observed without the addition of IL-2 to PBMC cultures may indicate that the proliferation of virus-specific CD8 ϩ T cells is reduced by defects in CD4 ϩ T cells. Indeed, we and others have shown that the proliferation of virus-specific CD4 ϩ T cells is severely impaired in the elderly.
Collectively, we conclude that during aging the precursor frequency of influenza A virus specific CTL does not fluctuate. Apparently the pool of memory CTL is maintained and repeated exposure to the virus does not increase this pool. The reported reduction of CTL activity in the elderly is most likely caused by other defects in CD8 ϩ T cells or other cells of the immune system.
MATERIALS AND METHODS
Human subjects
Blood samples of 10 ml were collected in heparincontaining vacutainers (Becton-Dickinson, Plymouth, U.K.) at the bloodbank in Rotterdam from 87 donors of various ages ranging from 18 to 70 years (Table 1) . Within 4 h after collection, the blood was diluted in PBS (1:1) , and the PBMC were isolated by gradient centrifugation using Lymphoprep (Nycomed, Oslo, Norway), as recommended by the manufacturer. The cells were washed three times in PBS and left overnight at 37°C in RPMI 1640 (Life Technologies, Rockville, MD) supplemented with 10% pooled human AB serum, streptomycin (100 U/ml), penicillin (100 g/ml), glutamine (2 mM), and 2-mercaptoethanol (2 M) (R10H). The plasma, 1:1 diluted in PBS, was collected and stored at Ϫ20°C. From two groups of donors, aged 18-20 years (n ϭ 5) and 68-70 years (n ϭ 5), buffy coats were obtained from which PBMC were isolated and cryopreserved as previously described (Boon et al., 2002a) . Before collecting blood, informed consent was obtained from each of the blood donors.
Preparation of B lymphoblastoid cell lines (BLCL)
Autologous Epstein-Barr virus (EBV)-transformed BLCL of each of the five young and five old donors was established by culturing 1-5 ϫ 10 6 PBMC in 1.0 ml culture supernatant from the EBV-producing cell line S594 in 24-well plates as previously described .
Influenza virus
Sucrose-gradient purified influenza A virus (H3N2) Resvir-9, a reassortant between A/Puerto Rico/8/34 (H1N1) and A/Nanchang/933/95 (H3N2), containing the hemagglutinin (HA), neuraminidase (NA), and nucleoprotein (NP) of A/Nanchang/933/95, was used for the infection of PBMC or BLCL. The infectious virus titer (1 ϫ 10 9 TCID 50 ) was determined in cell culture using Madin-Darby canine kidney (MDCK) cells as indicator cells as previously described (Rimmelzwaan et al., 1998) . For lymphocyte proliferation studies, Influvac 97/98 (kindly provided by Solvay Pharmaceuticals BV, Weesp, Netherlands), a trivalent vaccine consisting of the influenza virus glycoproteins HA and NA from A/Johannesburg/ 82/95 (H1N1), A/Nanchang/933/95 (H3N2), and B/Harbin/ 7/94, was used. 
Enumeration of influenza A virus specific T cells
PBMC were resuspended and washed twice in RPMI 1640 supplemented with 10% foetal calf serum (FCS), streptomycin (100 U/ml), penicillin (100 g/ml), and glutamine (2 mM) (R10F) to remove influenza virus specific antibodies present in the human serum. Subsequently, 1 ϫ 10 6 PBMC were infected for 1 h at 37°C with Resvir-9 at a multiplicity of infection (m.o.i.) of 3. Uninfected PBMC were included as a control. After 1-h incubation at 37°C, the PBMC were spun down, resuspended in R10H, and divided over two wells in a 96-well round-bottom Costar plate (Corning Inc., Corning, NY), with each well containing 3 ϫ 10 5 PBMC in 150 l R10H. After a previously determined optimal period of 5 h at 37°C, Golgistop (Pharmingen, San Diego, CA) was added and left for a subsequent 6 h at 37°C. Influenza virus specific T cells were visualised by intracellular IFN-␥ staining and flow cytometry (see below).
Enumeration of IFN-␥ and IL-4 producing T cells upon nonspecific stimulation
PBMC, 2 ϫ 10 5 cells per well, were stimulated with 50 ng/ml PMA (Sigma Chemical Co., St Louis, MO) and 500 ng/ml ionomycin (Sigma) for 6 h at 37°C in R10F. The percentage IFN-␥ and IL-4ϩ cells were determined using an intracellular cytokine staining protocol and flow cytometry (see below).
Intracellular cytokine staining and flow cytometry analysis
After stimulation of PBMC with PMA/ionomycin or influenza A virus, the cells were transferred to a V-bottomshaped 96-well plate and subsequently stained, fixed, and permeabilised with the Cytofix/Cytoperm kit (Pharmingen) according to instructions provided by the manufacturer. Briefly, PBMC were washed once in PBS with 2.0% FCS (P2F) and incubated with a mix of anti-human CD3-RPE-Cy5 (Dako, Glostrup, Denmark) and anti-human CD8-FITC (Dako) or anti-human CD3-RPE-Cy5 and anti-human CD4-FITC (Dako) in 50 l P2F for 30 min at 4°C. Following two washing steps with P2F, the cells were fixed with 100 l Cytofix buffer for 30 min at 4°C. Next, the cells were washed twice in permeabilisation buffer and subsequently incubated for 30 min at 4°C in 50 l permeabilisation buffer containing anti-human IFN-␥-PE (Pharmingen) or anti-human IL-4-PE (Pharmingen). After two washing steps with permeabilisation buffer, the cells were resuspended in P2F, and the number of cytokine-positive cells was determined using flow cytometry (FACS scan, Becton-Dickinson). The percentage of cytokine-positive cells within the CD4 ϩ or CD8 ϩ T cell fraction was obtained from one well, while the percentage of cytokine-positive cells within the CD3 ϩ T cells was calculated from duplicate wells. Sporadically we were un-able to determine the virus-specific precursor frequency. After stimulation with influenza virus, the percentage IFN-␥ϩ cells was determined within the CD3 ϩ , CD4 ϩ , and CD8 ϩ T cell compartments (Figs. 1A and 1B) , while after mitogenic stimulation, both the percentage of IFN-␥ϩ and the percentage IL-4ϩ cells were determined within CD8 ϩ T cell population and the percentage INF-␥ϩ cells were determined within CD3 ϩ cells. Results are given as the percentage cytokine-positive cells calculated from the percentage after stimulation with either influenza virus or mitogen minus unstimulated control cells. The cutoff value was calculated from the average percentage cytokine positive cells of the unstimulated PBMC plus one time the standard deviation (SD).
Serology
Serum samples were tested for the presence of influenza A virus specific antibodies in the HI test according to standard methods (Masurel et al., 1981; Palmer et al., 1975) using turkey erythrocytes and four hemagglutinating units of virus. The samples were tested against 10 influenza A virus (H3N2) vaccine strains from the introduction of H3N2 (A/HongKong/1/68) until one of the most recent H3N2 vaccine strain (A/Sydney/5/97) and for antibodies against nine influenza A virus (H1N1) strains, from the first isolate of H1N1 (A/Puerto Rico/8/34) until the latest H1N1 vaccine component (A/New Caledonia/ 20/99). Ferret sera raised against the test antigens were used as positive controls.
Phenotypic analysis of PBMC
Cryopreserved PBMC, from the groups of 18-to 20year-old and 68-to 70-year-old donors (n ϭ 10) were analysed for memory and naïve T cell phenotype and CD28 expression. Approximately 2 ϫ 10 5 PBMC were resuspended in 50 l P2F and incubated for 30 min at 4°C with different combinations of MAb. For the staining of T lymphocytes MAb directed to human CD3 (Dako), CD4 (Dako), CD8 (Dako), CD45RA-FITC (Pharmingen), CD45RO-Cy-Chrome (Pharmingen), and CD28-RPE (Pharmingen) were used. The cells were subsequently washed once in P2F and analysed by flow cytometry.
Proliferative response of donor PBMC
To determine their proliferative capacity, PBMC (1 ϫ 10 5 ) of donors between 18 and 20 or 68 and 70 years of age were transferred to a U-bottom-shaped 96-well plate in 150 l R10H and stimulated with a twofold serial dilution of Influvac 97/98, starting at 2.0 g/ml HA per virus strain. A medium control was included to determine nonspecific proliferation. After a 5-day incubation at 37°C, 0.5 Ci [ 3 H]thymidine was added to each well and subsequently incubated for 18 h at 37°C prior to harvesting. Results were calculated from triplicate wells and given as the average counts per minute (cpm) of all donors ϩ the standard error of the mean (SEM).
Generation of influenza A virus specific CTL effector cells from PBMC
To assess influenza A virus specific CTL activity in vitro, PBMC were stimulated with Resvir-9 as previously described (Boon et al., 2002a) . Briefly, 5 ϫ 10 6 PBMC were infected with Resvir-9 at an m.o.i. of 3 for 1 h at 37°C in R10F. Following centrifugation, the PBMC were resuspended in R10H and added to uninfected PBMC at a ratio of 1:1. After 2 days at 37°C, rIL-2 (50 U/ml final concentration) was added, and the cells were incubated for another 6 days. Prior to the CTL assay CD4 ϩ cells were depleted using M-450 Dynabeads (Dynal, Oslo, Norway), followed by the depletion of NK cells with anti-human CD16 MAb (Pharmingen) coupled to Pan anti-mouse IgG beads (Dynal) according to manufacturer's instructions. The remaining effector cell population was used to assess the lytic ability of effector cells. The depletion of CD4 ϩ and CD16 ϩ cells was validated on every occasion and the percentage CD4 ϩ CD3 ϩ cells and CD16 ϩ CD3 Ϫ cells was determined by flow cytometry. Contamination with these cell populations never exceeded 2.0%. The percentage CD8 ϩ CD3 ϩ T cells in the remaining effector cell population was determined to calculate the CD8:Target (CD8:T) cell ratio used in the cytotoxicity assay.
Cytotoxicity assay
Autologous BLCL were used as target cells and infected with Resvir-9 at an m.o.i. of 1 for 1 h at 37°C, spun down, and resuspended in R10F. After 16 h at 37°C, influenza A virus infected BLCL and uninfected BLCL were washed in serum-free medium and labeled for 1 h at 37°C with 50 Ci Na 2 [ 51 Cr]O 4 per 5 ϫ 10 5 cells. Following three washing steps with R10F, the target cells were added to effector cells at different CD8:Target cell ratios for 4 h at 37°C and the supernatant was subsequently harvested. The percentage specific lysis was calculated with the following formula: ((experimental release Ϫ spontaneous release)/(maximal release Ϫ spontaneous release)) ϫ 100. The average percentage specific lysis was calculated from a minimum of three wells and given as the percentage lysis of virus-infected autologous BLCL minus the percentage lysis of uninfected autologous BLCL. The slope of each plot was calculated with the logarithmic trendline between CD8: Target cell ratio and the percentage specific lysis.
Statistical analysis
The relationship between percentage cytokine positive cells and age was calculated with a two-tailed Pearson bivariate correlation assay. P values below 0.05 were considered statistically significant. The statistical signif-icance in lytic ability of effector cells and proliferation of PBMC obtained from 18-to 20-year-old and 68-to 70year-old donors was determined with Student's t test.
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